Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Clinical outcomes of compensated and decompensated cirrhosis: A long term study.

Samonakis DN, Koulentaki M, Coucoutsi C, Augoustaki A, Baritaki C, Digenakis E, Papiamonis N, Fragaki M, Matrella E, Tzardi M, Kouroumalis EA.

World J Hepatol. 2014 Jul 27;6(7):504-12. doi: 10.4254/wjh.v6.i7.504.

PMID:
25068002
[PubMed]
Free PMC Article
2.

KASL clinical practice guidelines: management of hepatitis C.

Korean Association for the Study of the Liver (KASL).

Clin Mol Hepatol. 2014 Jun;20(2):89-136. doi: 10.3350/cmh.2014.20.2.89. Epub 2014 Jun 30. No abstract available.

PMID:
25032178
[PubMed - in process]
Free PMC Article
3.

How to define transarterial chemoembolization failure or refractoriness: a European perspective.

Raoul JL, Gilabert M, Piana G.

Liver Cancer. 2014 May;3(2):119-24. doi: 10.1159/000343867. Review.

PMID:
24945002
[PubMed]
Free PMC Article
4.

The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update.

Liu M, Jiang L, Guan XY.

Protein Cell. 2014 Sep;5(9):673-91. doi: 10.1007/s13238-014-0065-9. Epub 2014 Jun 11.

PMID:
24916440
[PubMed - in process]
5.

Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.

Zeng QL, Feng GH, Zhang JY, Chen Y, Yang B, Huang HH, Zhang XX, Zhang Z, Wang FS.

World J Gastroenterol. 2014 May 14;20(18):5519-26. doi: 10.3748/wjg.v20.i18.5519.

PMID:
24833882
[PubMed - in process]
Free PMC Article
6.

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand.

Tantai N, Chaikledkaew U, Tanwandee T, Werayingyong P, Teerawattananon Y.

BMC Health Serv Res. 2014 Apr 14;14:170. doi: 10.1186/1472-6963-14-170.

PMID:
24731689
[PubMed - in process]
Free PMC Article
7.

A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis.

Ydreborg M, Lisovskaja V, Lagging M, Brehm Christensen P, Langeland N, Buhl MR, Pedersen C, Mørch K, Wejstål R, Norkrans G, Lindh M, Färkkilä M, Westin J.

PLoS One. 2014 Apr 3;9(4):e93601. doi: 10.1371/journal.pone.0093601. eCollection 2014.

PMID:
24699777
[PubMed - in process]
Free PMC Article
8.

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.

Lau T, Ahmad J.

Hepat Med. 2013 Feb 11;5:1-10. doi: 10.2147/HMER.S9049. eCollection 2013. Review.

PMID:
24696621
[PubMed]
Free PMC Article
9.

Direct-acting antiviral agents in patients with hepatitis C cirrhosis.

Im GY, Dieterich DT.

Gastroenterol Hepatol (N Y). 2012 Nov;8(11):727-65.

PMID:
24672409
[PubMed]
Free PMC Article
10.

Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis.

González-Ojeda A, Cervantes-Guevara G, Chávez-Sánchez M, Dávalos-Cobián C, Ornelas-Cázares S, Macías-Amezcua MD, Chávez-Tostado M, Ramírez-Campos KM, Ramírez-Arce Adel R, Fuentes-Orozco C.

World J Gastroenterol. 2014 Feb 28;20(8):2079-84. doi: 10.3748/wjg.v20.i8.2079.

PMID:
24616574
[PubMed - in process]
Free PMC Article
11.

Cost-effectiveness of Telaprevir combination therapy for chronic hepatitis C.

Brogan AJ, Talbird SE, Thompson JR, Miller JD, Rubin J, Deniz B.

PLoS One. 2014 Mar 6;9(3):e90295. doi: 10.1371/journal.pone.0090295. eCollection 2014.

PMID:
24603445
[PubMed - in process]
Free PMC Article
12.

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus.

Bruno S, Savojardo D, Almasio PL, Mondelli MU.

Hepat Med. 2011 Mar 30;3:21-8. doi: 10.2147/HMER.S16991. Review.

PMID:
24367218
[PubMed]
Free PMC Article
13.

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil.

Barros FM, Cheinquer H, Tsuchiya CT, Santos EA.

Cost Eff Resour Alloc. 2013 Oct 8;11(1):25. doi: 10.1186/1478-7547-11-25.

PMID:
24103591
[PubMed]
Free PMC Article
14.

Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.

Corchado S, Márquez M, Montes de Oca M, Romero-Cores P, Fernández-Gutiérrez C, Girón-González JA.

PLoS One. 2013 Jun 26;8(6):e66619. Print 2013.

PMID:
23840511
[PubMed - as supplied by publisher]
Free PMC Article
15.
16.

Epidemiology of hepatocellular carcinoma: consider the population.

Mittal S, El-Serag HB.

J Clin Gastroenterol. 2013 Jul;47 Suppl:S2-6. doi: 10.1097/MCG.0b013e3182872f29. Review.

PMID:
23632345
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.

Ferrante SA, Chhatwal J, Brass CA, El Khoury AC, Poordad F, Bronowicki JP, Elbasha EH.

BMC Infect Dis. 2013 Apr 27;13:190. doi: 10.1186/1471-2334-13-190.

PMID:
23621902
[PubMed - in process]
Free PMC Article
18.

Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review.

Bota S, Sporea I, Sirli R, Popescu A, Neghină AM, Dănilă M, Străin M.

World J Hepatol. 2013 Mar 27;5(3):120-6. doi: 10.4254/wjh.v5.i3.120.

PMID:
23556044
[PubMed]
Free PMC Article
19.

Liver transplantation().

Rossi M, Mennini G, Lai Q, Ginanni Corradini S, Drudi FM, Pugliese F, Berloco PB.

J Ultrasound. 2007 Mar;10(1):28-45. doi: 10.1016/j.jus.2007.02.006. Epub 2007 Apr 16.

PMID:
23396075
[PubMed]
Free PMC Article
20.

Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients.

Che L, Yuan YH, Jia J, Ren J.

Chin J Cancer Res. 2012 Dec;24(4):323-31. doi: 10.3978/j.issn.1000-9604.2012.10.10.

PMID:
23359030
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk